SCIENTIFIC COMMITTEE

N. Ciavarella

ITALY

Nicola Ciavarella

Former Director of the Hemophilia and Thrombosis Center of the Bari University Hospital. Coordinator of the Technical Panel on Thrombosis of the Apulia Region, Bari, Italy

A. B. Federici

ITALY

Augusto Federici

Associate Professor of Hematology at the Department of Internal Medicine, University of Milan and Head of Hematology and Transfusion Medicine at the University Hospital L. Sacco of Milan, Italy

F. Peyvandi

ITALY

Flora Peyvandi

Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Fondazione IRCCS Ca’ Granda, Ospedale Maggiore Policlinico, University of Milan, Milan, Italy

P. M. Mannucci

ITALY

Pier Mannuccio Mannucci

Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Milan, Italy

SPEAKERS

L. M. Aledort

USA

Professor of Medicine, Hematology and Medical Oncology - Icahn Mount Sinai School of Medicine - New York, USA
Title:"The challenges of innovative therapeutic interventions in hemophilia"

M. Carcao

CANADA

Associate Professor – Hospital for Sick Children, Hemophilia Clinic, Toronto (ON), Canada.
Preliminary Title: "Will severe hemophilia become more common in future? The effects of populations demographics on the incidence of hemophilia

G. Castaman

ITALY

Director of Center for Bleeding Disorders and Coagulation, Department of Oncology, Careggi University Hospital, Florence, Italy

P. Coppo

FRANCE

French reference Center for Thrombotic Microangiopathies; Professor of Haematology at Saint-Antoine Hospital, Paris, France. Preliminary title: "Acquired TTP: are we ready for a prognosis-dependent management?"

M. Cugno

ITALY

Department of medical, surgical and transplant physiopathology of the University of Milan, Fondazione IRCCS Ca’ Granda, Ospedale Maggiore Policlinico, University of Milan, Milan, Italy.
Preliminary title: "Treatment monitoring in the atypical hemolytic uremic syndrome (HUS)"

S. De Meyer

BELGIUM

Associate Professor at the Laboratory for Thrombosis Research, KU Leuven Kulak, Kortrijk, Belgium
Preliminary title: "Von Willebrand factor in ischemic stroke"

C. Denis

FRANCE

Institut National de la Santé et de la Recherche Médicale (INSERM) U1176, Le Kremlin-Bicetre, France.
Preliminary title: "The many faces of thrombocytopenia in von Willebrand disease type 2B"

G. Di Minno

ITALY

Department of Clinical and Experimental Medicine, University of Naples Federico II, Naples, Italy
Title:"Predictors of outcome in ITI: the Italian Registry"

V. Flood

USA

Children's Hospital of Wisconsin-Milwaukee Campus, Milwaukee, USA.
Preliminary title: "Collagen and VWF interactions and beyond."

M. Franchini

ITALY

Servizio di immunoematologia e trasfusione, Azienda Ospedaliera Carlo Poma, Mantova, Italy

A. C. Goodeve

UK

Head of Sheffield Haemostasis Research Group – Department of Infection, Immunity & Cardiovascular Disease – Faculty of Medicine, Dentistry and Health – University of Sheffield, Sheffield, UK.
Preliminary title: "The genetics of von Willebrand disease: recent developments."

J. A. Kremer Hovinga

SWITZERLAND

Head of the Hemostasis Research Laboratory at Berne University Hospital, Bern, Switzerland

S. Lacroix-Desmazes

FRANCE

Institut National de la Santé et de la Recherche Médicale (INSERM), UMRS 1138, Centre de Recherche des Cordeliers Paris, France
Preliminary title: "Endocytosis of factor FVIII by antigen-presenting cells: roles of von Willebrand factor and complement"

J. C. Laurence

USA

Professor of Medicine, Weill Cornell Medical College, and Attending Physician, New York Presbyterian Hospital-Cornell, New York, USA
Preliminary title: "Differential diagnosis of thrombotic microangiopathies"

P. J. Lenting

FRANCE

Inserm U770, Le Kremlin-Bicêtre, France.
Preliminary title: "The potential use of nanobodies in the treatment of VWD and hemophilia."

D. Lillicrap

CANADA

Department of Pathology and Molecular Medicine, Richardson Laboratory, Queen’s University, Kingston (ON), Canada.
Preliminary title: "Determinants of FVIII inhibitor risk: Is VWF a key factor?"

J. A. López

USA

Bloodworks Northwest Research Institute – Professor of Medicine, Division of Hematology – University of Washington – School of Medicine, Seattle, USA

M. Makris

UK

Professor of Haemostasis and Thrombosis at University of Sheffield and Director of the Sheffield Haemophilia and Thrombosis Centre, Sheffield, UK

D. Meyer

FRANCE

Professeur émérite d'hématologie, Université Paris XI, Académie des sciences, Paris, France

F. Mingozzi

FRANCE

Associate Professor, University Pierre and Marie Curie, Paris, Team Leader, Genethon, Evry, France
Prelimiary Title: "Addressing vector immunogenicity in the development of AAV-based gene therapies for bleeding disorders"

R. R. Montgomery

USA

Pediatric hematologist at the Blood Research Institute in Milwaukee, USA

L. Naldini

ITALY

Director of the San Raffaele Telethon Institute for Gene Therapy and Professor at the San Raffaele University, Milan, Italy
Title: "Liver-directed lentiviral gene therapy of hemophilia".

A. Nathwani

UK

Research Department of Haematology, Cancer Institute, Faculty of Medical Sciences, London, UK
Preliminary title: "An update on UCL/St Jude Haemophilia studies; successes and obstacles ahead".

M. Noris

ITALY

Laboratory of Immunology and Genetics of Rare Diseases – IRCCS-Mario Negri Institute for Pharmacological Research – Ranica (BG), Italy

J. Oldenburg

GERMANY

Chairman and Director of the University Clinic Bonn Institute of Experimental Haematology and Transfusion Medicine, Bonn, Germany

A. M. Randi

UK

Professor of Cardiovascular Medicine – Imperial Centre for Translational and Experimental Medicine – Imperial College London NHLI Vascular Sciences – Hammersmith Hospital – London, UK.
Preliminary title: "VWF regulation of blood vessel formation and function."

G. Remuzzi

ITALY

Professor of Nephrology, Mario Negri Institute for Pharmacological Research – Centro Anna Maria Astori – Science and Technology Park “Kilometro Rosso”, Bergamo, Italy. Preliminary title: "The most recent advances in aHUS and TTP including complement and VWF-complement interactions."

F. R. Rosendaal

THE NETHERLANDS

Professor of Clinical Epidemiology, Leiden University Medical Center, Leiden, the Netherlands
Title: "Randomisation or real world data?"

Z. M. Ruggeri

USA

Department of Molecular and Experimental Medicine, Scripps Clinic, La Jolla (CA), USA.
Preliminary title: "Old concepts and new functions of von Willebrand factor: 2017."

M. Shima

JAPAN

Department of Pediatrics, Nara Medical University – Nara, Japan
Preliminary Title: "Paradigm shift of the treatment of hemophilia A by FVIII mimicking bispecific antibody"

K. Vanhoorelbeke

BELGIUM

Faculty of Science, Campus Kulak Kortrijk, KU Leuven Kortrijk, Belgium.
Preliminary title: "Emerging concepts in acquired thrombotic thrombocytopenic purpura."

J. Voorberg

THE NETHERLANDS

Department of Plasma Proteins – Sanquin Research and University of Amsterdam, Amsterdam, the Netherlands
Preliminary Title: "Immune recognition of ADAMTS13 in acquired TTP"

D. Wagner

USA

Edwin Cohn Professor of Pediatrics
Center for Blood Research Professor of Pediatrics, Program in Cellular and Molecular Medicine and Div. of Hematology / Oncology. Boston Children's Hospital. Harvard Medical School, Boston, USA.
Preliminary Title: "Interplay between VWF/ADAMTS13 and NETs"

L. Walsh

USA

.
Preliminary Title: "Gene therapy in hemophilia A"

X.L. Zheng

USA

Robert B. Adams Endowed Professor and Director, Laboratory Medicine - Interim Director, Informatics - Department of Pathology UAB, the University of Alabama at Birmingham, AL, USA
Preliminary title: "Mechanism of thrombotic microangiopathy: lesson from zebrafish to men"